![Colin Hislop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colin Hislop
Plus aucun poste en cours
Profil
Colin Hislop formerly worked at Eli Lilly & Co., as Principal, Procter & Gamble Co., as Manager-Clinical Development, CV Therapeutics, Inc., as Vice President-Clinical Development in 2004, Peninsula Pharmaceuticals, Inc., as Vice President-Clinical Development in 2005, Anthera Pharmaceuticals, Inc., as Chief Medical Officer & Senior Vice President from 2010 to 2016, Versartis, Inc., as Chief Development Officer in 2017, and Eiger BioPharmaceuticals, Inc., as Senior VP-Clinical & Development Operations.
Dr. Hislop received his doctorate degree from the University of London and undergraduate degree from the University of Surrey.
Anciens postes connus de Colin Hislop
| Sociétés | Poste | Fin |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/03/2024 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Directeur Technique/Scientifique/R&D | 05/09/2017 |
| ANTHERA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2016 |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Directeur Technique/Scientifique/R&D | 01/06/2005 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Directeur Technique/Scientifique/R&D | 01/09/2004 |
Formation de Colin Hislop
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
